Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 5369-19-7 | MDL No. : | MFCD00125078 |
Formula : | C10H15N | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DPKTVUKEPNBABS-UHFFFAOYSA-N |
M.W : | 149.23 | Pubchem ID : | 79334 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.4 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 0.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 50.12 |
TPSA : | 26.02 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.1 cm/s |
Log Po/w (iLOGP) : | 2.02 |
Log Po/w (XLOGP3) : | 2.97 |
Log Po/w (WLOGP) : | 2.57 |
Log Po/w (MLOGP) : | 2.76 |
Log Po/w (SILICOS-IT) : | 2.26 |
Consensus Log Po/w : | 2.52 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 2.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.97 |
Solubility : | 0.158 mg/ml ; 0.00106 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.18 |
Solubility : | 0.0987 mg/ml ; 0.000661 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.23 |
Solubility : | 0.0881 mg/ml ; 0.00059 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
95% | With palladium 10% on activated carbon; hydrazine hydrate In methanol at 120℃; for 0.25 h; Microwave irradiation; Sealed tube | General procedure: To amixture of halogenated nitroarene (1 mmol), Pd/C(10percent),and MeOH (5 mL) was added NH2NH2·H2O (10 mmol), andthe resulting solution was heated at 120 °C by BiotageInitiator Classic microwave synthesizer for 15 min. Themixture was filtered and condensed in vacuo. The crudematerial was purified by flash column chromatographyusing hexanes and EtOAc. |
[ 92050-16-3 ]
5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine
Similarity: 0.94
[ 2479-47-2 ]
4,4'-(Propane-2,2-diyl)dianiline
Similarity: 0.94
[ 92050-16-3 ]
5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-amine
Similarity: 0.94
[ 2479-47-2 ]
4,4'-(Propane-2,2-diyl)dianiline
Similarity: 0.94